| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K R Purushotham, W A Dunn, C A Schneyer, M G Humphreys-Behe. A novel mechanism for isoprenaline-stimulated proliferation of rat parotid acinar cells involving the epidermal growth factor receptor and cell surface galactosyltransferase. The Biochemical journal. vol 284 ( Pt 3). 1992-08-04. PMID:1622394. |
chronic injections of epidermal growth factor (egf) or the beta-adrenergic receptor agonist isoprenaline resulted in rat parotid gland hypertrophy and hyperplasia. |
1992-08-04 |
2023-08-11 |
rat |
| J Mészáro. Sodium-pump injury and arrhythmogenic transient depolarizations in catecholamine-induced cardiac hypertrophy. European journal of pharmacology. vol 210. issue 3. 1992-07-29. PMID:1319336. |
in hypertrophy induced by administration of 5 mg/kg isoprenaline once daily for 7 days, the myocardial membrane was depolarized, the action potential duration was prolonged and the vmax was decreased, as compared with those of age-matched normal controls. |
1992-07-29 |
2023-08-11 |
rat |
| J Mészáros, G Léva. Catecholamine-induced cardiac hypertrophy uncouples beta-adrenoceptors from slow calcium channels. European journal of pharmacology. vol 210. issue 3. 1992-07-29. PMID:1319337. |
hypertrophy was induced by administration of 5 mg/kg isoproterenol once daily for 7 days. |
1992-07-29 |
2023-08-11 |
rat |
| R Kolarova, O Petkov, N Popov. Changes in the enzyme activity of the myocardium and participation of the alpha-adrenergic and M-cholinergic systems in experimental isoprenaline myocardial hypertrophy. Acta physiologica et pharmacologica Bulgarica. vol 17. issue 2-3. 1992-07-24. PMID:1668133. |
changes in the enzyme activity of the myocardium and participation of the alpha-adrenergic and m-cholinergic systems in experimental isoprenaline myocardial hypertrophy. |
1992-07-24 |
2023-08-11 |
rat |
| R Kolarova, O Petkov, N Popov. Changes in the enzyme activity of the myocardium and participation of the alpha-adrenergic and M-cholinergic systems in experimental isoprenaline myocardial hypertrophy. Acta physiologica et pharmacologica Bulgarica. vol 17. issue 2-3. 1992-07-24. PMID:1668133. |
with a view to clarifying the mechanisms of haemodynamic stress, as well as the role of some neurotransmitter systems in the pathogenesis of myocardial hypertrophy (mh), a complex of experiments was carried out with an mh model induced in rats by isoprenaline treatment and by applying the m-cholinolytic agent atropine and the alpha-adrenergic blocker phentolamine in a part of the experimental groups. |
1992-07-24 |
2023-08-11 |
rat |
| M Nagano, J Higaki, F Nakamura, K Higashimori, N Nagano, H Mikami, T Ogihar. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension (Dallas, Tex. : 1979). vol 19. issue 6 Pt 2. 1992-06-30. PMID:1534315. |
to examine the role of ang ii in left ventricular (lv) hypertrophy, isoproterenol was infused subcutaneously into 9-week-old male wistar rats at 4.2 mg/kg/day for 7 days. |
1992-06-30 |
2023-08-11 |
rat |
| P S Sunga, S W Rabki. Reversal of angiotensin II effect on the cyclic adenosine 3',5' monophosphate response to isoprenaline in cardiac hypertrophy. Cardiovascular research. vol 25. issue 11. 1992-06-12. PMID:1667504. |
reversal of angiotensin ii effect on the cyclic adenosine 3',5' monophosphate response to isoprenaline in cardiac hypertrophy. |
1992-06-12 |
2023-08-11 |
Not clear |
| P S Sunga, S W Rabki. Reversal of angiotensin II effect on the cyclic adenosine 3',5' monophosphate response to isoprenaline in cardiac hypertrophy. Cardiovascular research. vol 25. issue 11. 1992-06-12. PMID:1667504. |
the aim was to examine the effect of angiotensin ii on the response of hypertrophic cardiac myocytes to the beta adrenergic receptor agonist isoprenaline. |
1992-06-12 |
2023-08-11 |
Not clear |
| J Perennec, M Willemin, P Pocholle, P Y Hatt, B Crozatie. Cardiac ultrastructural abnormalities in Syrian hamsters with spontaneous cardiomyopathy or subjected to cardiac overloads. Basic research in cardiology. vol 87. issue 1. 1992-05-21. PMID:1533119. |
ultrastructural and morphometric abnormalities of syrian hamster cardiomyopathy were compared to those observed in two different models of cardiac hypertrophy produced by mechanical overload (abdominal aortic stenosis, 60-day duration) or by isoproterenol injection during 15 days in normal syrian hamsters of the same strain. |
1992-05-21 |
2023-08-11 |
Not clear |
| N Maeda, K R Purushotham, M M Koller, M G Humphreys-Behe. Regulation of cell-surface galactosyltransferase in isoproterenol-treated mouse parotid glands. Archives of oral biology. vol 36. issue 7. 1992-03-04. PMID:1776922. |
chronic injection of isoproterenol into mice resulted in hypertrophy and hyperplasia of the parotid gland. |
1992-03-04 |
2023-08-11 |
mouse |
| C M Brandt, J M Boulenc, T Carrière, A Verdun, J L Imb. [Hypertrophic cardiomyopathy with left ventricular dynamic obstruction syndrome in hypertensive adult patients]. Presse medicale (Paris, France : 1983). vol 20. issue 39. 1992-02-11. PMID:1837084. |
seven adult patients with old and severe arterial hypertension were found to have hypertrophic cardiomyopathy with left ventricular obstruction demonstrated by an isoproterenol test. |
1992-02-11 |
2023-08-11 |
Not clear |
| J Mészáros, G Léva. Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure. Acta biologica Hungarica. vol 41. issue 4. 1991-12-19. PMID:2151869. |
cardiac hypertrophy and failure were induced in male wistar rats by daily administration of 5 mg/kg isoproterenol for three weeks. |
1991-12-19 |
2023-08-11 |
rat |
| J Mészáros, G Léva. Ultrastructural and electrophysiological alterations during the development of catecholamine-induced cardiac hypertrophy and failure. Acta biologica Hungarica. vol 41. issue 4. 1991-12-19. PMID:2151869. |
the results indicate that an electrically and structurally compensated cardiac hypertrophy model can be produced by a short-term treatment of the animals with isoproterenol, while a long-term treatment causes a decompensated heart failure. |
1991-12-19 |
2023-08-11 |
rat |
| R Hilal-Dandan, P A Khairalla. Cyclic AMP in myocytes isolated from hypertrophied rat hearts. Journal of molecular and cellular cardiology. vol 23. issue 6. 1991-12-13. PMID:1658343. |
reduced inotropic responsiveness to isoproterenol stimulation in the hypertrophied hearts of the shr and the rhr, both models of pressure overload hypertrophy, involve different biochemical alterations. |
1991-12-13 |
2023-08-11 |
rat |
| M Shimizu, O Irimajiri, T Nakano, T Mizokami, K Ogawa, J Sanjo, H Yamada, H Sasaki, Y Isoga. Effect of captopril on isoproterenol-induced myocardial ornithine decarboxylase activity. Journal of molecular and cellular cardiology. vol 23. issue 6. 1991-12-13. PMID:1719221. |
these results indicate that the renin-angiotensin system may participate in the induction of myocardial hypertrophy by isoproterenol. |
1991-12-13 |
2023-08-11 |
rat |
| T Eschenhagen, U Mende, M Nose, W Schmitz, H Scholz, A Warnholtz, J M Wüste. Isoprenaline-induced increase in mRNA levels of inhibitory G-protein alpha-subunits in rat heart. Naunyn-Schmiedeberg's archives of pharmacology. vol 343. issue 6. 1991-12-13. PMID:1834950. |
for comparison rats were treated with triiodothyronine (t3; 0.5 mg/kg.d) which induces cardiac hypertrophy like isoprenaline but has different effects on the adenylyl cyclase system. |
1991-12-13 |
2023-08-11 |
rat |
| K Iida, Y Sugishita, K Yukisada, K Fujieda, I It. Diastolic properties of hypertrophied hearts in essential hypertension: classification by left ventricular wall stress. Journal of cardiology. vol 20. issue 3. 1991-12-02. PMID:2151865. |
these results suggest that hypertensive patients with inappropriate hypertrophy have relatively diminished diastolic velocity (supernormal systolic velocity and normal diastolic velocity) before and during isoproterenol infusion, and that hypertensive patients with appropriate hypertrophy have absolutely diminished diastolic velocity during isoproterenol infusion, in spite of normal diastolic velocity before the infusion. |
1991-12-02 |
2023-08-11 |
human |
| K Prodanov, R Kolarova, L Tsakova, M Balutso. [Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats]. Eksperimentalna meditsina i morfologiia. vol 30. issue 1. 1991-10-09. PMID:1832104. |
isoproterenol, administered intraperitoneally in rats in a dose of 2 mg/kg of body mass for a period of 20 days, induced myocardial hypertrophy. |
1991-10-09 |
2023-08-11 |
rat |
| G Agnoletti, A F Panzali, A Cornacchiari, F De Giuli, R Ferrar. Effects of prolonged infusions of atrial natriuretic peptide and isoproterenol on the mechanical and endocrine function of isolated atria. Cardioscience. vol 1. issue 3. 1991-10-03. PMID:2151714. |
infusion of isoproterenol caused hypertrophy of the left chambers of the heart, a decrease of atrial content of atrial peptide with increased plasma levels. |
1991-10-03 |
2023-08-11 |
rat |
| C M Taquini, H Gómez Llambi, A Mazzadi, M Fontan, A Gall. Improvement of cardiac contractile response to beta-adrenergic stimulation in normal and two-kidney, one-clip hypertensive rats treated with nitrendipine. Journal of cardiovascular pharmacology. vol 17 Suppl 2. 1991-10-01. PMID:1715476. |
to evaluate the effect of nitrendipine on cardiac hypertrophy and inotropic response to isoproterenol in two-kidney, one-clip (2k,1c) renovascular hypertension, male wistar rats (n = 56) were divided into a clipped group (k) (n = 28) and a sham group (s) (n = 28). |
1991-10-01 |
2023-08-11 |
rat |